Site Search
Search Results
Lawmakers can improve the odds in New Yorkers' battles against cancer
... burden of their diagnosis. The next step in minimizing cancer’s burden should be to ensure that New Yorkers who could benefit have access to biomarker testing--a critical component of precision medicine. The results of these biomarker tests can help match patients with the right treatment at the right time. Recent studies show that biomarker testing can improve outcomes ...
Steps Governor Hochul Can Take to Make New York a Leader in Health Equity
... a bold step in health policy and greater accessibility to precision medicine technologies. ACS CAN proposes that New York improve access to biomarker testing—a technology that enables oncologists to provide the right treatment for the right patient at the right time. Allowing oncologists to ... treatment with precision medicine can lead to better outcomes. Right now, not all communities are benefiting from the latest advancements in biomarker testing and precision medicine. Many health insurance plans in New York, including Medicaid, may not cover the most appropriate biomarker ...
Advocates Set Sights on Cancer Prevention & Detection in 2024, Respond to Governor’s Budget with Avenues to Reduce Cancer Burden in NY
... Relations Director Michael Davoli: “In 2023, New York State delivered for its residents, prioritizing access to care with the passage of the biomarker testing bill. This legislation will equip countless New Yorkers who have received a cancer diagnosis with critical information about their disease ... their voices heard, ACS CAN influences legislative and regulatory solutions that will end cancer as we know it. 0 Four weeks after historic biomarker testing bill was signed into law, ACS CAN reacts to Governor’s budget and unveils its legislative vision for 2024 Advocates Set Sights ...